Co-morbidity of Diabetes and Tuberculosis Can Affect the Results of Treatment; A Case Control Study in Iran

  • سال انتشار: 1401
  • محل انتشار: مجله علوم پزشکی ایران، دوره: 10، شماره: 3
  • کد COI اختصاصی: JR_JHES-10-3_003
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 91
دانلود فایل این مقاله

نویسندگان

Mahdi Afshari

Pediatric Gastroenterology and Hepatology Research Center

Motahareh Kheradmand

Health Sciences Research Center, Addiction Institute

Mohsen Aarabi

Department of Family Medicine

Mohammadreza Parsaee

Health deputy

Fatemeh Roozbeh

Health deputy

Asghar Nezammahalleh

Health deputy

Keyvan Heydari

Student Research Committee, School of Medicine,

Maryam Zakian

Department of General Courses,

Mahmood Moosazadeh

Gastrointestinal Cancer Research Center, Non -communicable Diseases Institute

چکیده

Background and Purpose: Several evidences have shown some synergistic effect of diabetes co-morbidity on the tuberculosis (TB) treatment results, while some other studies have not found such associations. This study aimed to investigate the relationship between TB-diabetes co-morbidity and outcomes of TB treatment. Materials and Methods: The research population in this case control study were patients with smear positive tuberculosis. The cases were ۱۵۸ patients with TB and diabetes selected by consensus method, while controls were ۳۱۶ patients randomly selected from TB patients without diabetes. Results: Frequency of unfavorable outcome among cases was higher than among controls (۷.۶% vs ۷.۳% respectively, p-value =۰.۹۰۱). Multivariate logistic regression models showed that the odds ratios for adverse treatment outcome, death, treatment failure, positive smear after the intensive phase of treatment and high grade positivity (۲+ & ۳+) were ۰.۹۷(۰.۴۵- ۲.۰۶), ۰.۹۷(۰.۴۲-۲.۲۴), ۰.۹۱(۰.۱۷-۴.۸۵), ۱.۳۹(۰.۷۹- ۲.۴۴) and ۲.۵۷(۰.۸۳- ۷.۹۲) respectively. Moreover, treatment adverse outcomes among patients with drug complications (۲۲.۲% vs. ۶.۵%, p-value =۰.۰۱۰) and rural residents (۱۰% vs ۴.۹% respectively, p-value =۰.۰۳۷) were significantly higher than those among patients without complication and urban residents respectively. Conclusion: Although we did not observe any significant association between TB-diabetes co-morbidity and treatment results, there was a significant effect measure regarding the effect of smear positivity at the end of the intensive phase of treatment, especially high grade of smear positivity. Because of probable bias in the classification of the exposure, screening of TB patients regarding diabetes mellitus at the beginning of the treatment is recommended.

کلیدواژه ها

Tuberculosis, Diabetes, Death, Treatment Failure

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.